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2	
Abstract 22	
Rationale 23	
The adult mammalian heart has little regenerative capacity after myocardial infarction (MI) while 24	
neonatal mouse heart regenerates without scarring or dysfunction. However, the underlying pathways 25	
are poorly defined. 26	
Objective 27	
We sought to derive insights into the pathways regulating neonatal development of the mouse heart and 28	
cardiac regeneration post-MI. 29	
Methods and Results 30	
Total RNA-seq of normal mouse heart through the first 10 days of postnatal life revealed a previously 31	
unobserved transition in microRNA expression between P3 and P5 that associates specifically with 32	
altered expression of protein-coding genes on the focal adhesion pathway and cessation of 33	
cardiomyocyte cell division. We also found profound changes in the coding and non-coding 34	
transcriptome after neonatal MI, with evidence of essentially complete healing by P10. Over two thirds 35	
of each of the mRNAs, lncRNAs and microRNAs that were differentially expressed in the post-MI 36	
heart were also differentially expressed during normal postnatal development, suggesting a common 37	
regulatory pathway for normal cardiac development and post-MI cardiac regeneration. We selected 38	
exemplars of miRNAs that were implicated in our data set as regulators of cardiomyocyte proliferation. 39	
Several of these showed evidence of a functional influence on mouse cardiomyocyte cell division. In 40	
addition, a subset of these microRNAs, miR-144-3p, miR-195a-5p, miR-451a and miR-6240 showed 41	
evidence of functional conservation in human cardiomyocytes. 42	
Conclusions 43	
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The sets of mRNAs, miRNAs and lncRNAs that we report here merit further investigation as 44	
gatekeepers of cell division in the postnatal heart and as targets for extension of the period of cardiac 45	
regeneration beyond the neonatal period. 46	
  47	
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Background 48	
Heart disease is amongst the commonest causes of death worldwide [1]. Whilst planarians, teleost fish 49	
and some amphibians have the ability to regrow limbs or organs including the heart [2-4], mammals are 50	
limited in their regenerative abilities [5, 6]. Following myocardial infarction (MI), damaged 51	
myocardium is replaced by scar tissue triggering cardiac remodelling and impaired cardiac function [7, 52	
8]. 53	
A major barrier to cardiac regeneration in adult mammals is the withdrawal of the cardiomyocyte from 54	
the cell cycle in early postnatal life. In the mouse, although DNA replication continues in the first week 55	
of postnatal life, cytokinesis ceases. By the second week of life, mouse cardiomyocytes withdraw from 56	
the cell cycle, 90% of cardiomyocytes are binucleated and, aside from a recent report of a proliferative 57	
burst at P15 [9], recently contested [10], heart growth after the first week of life occurs mainly through 58	
cardiomyocyte hypertrophy rather than proliferation [11, 12]. This programme of cell cycle arrest is 59	
hypothesised to result from metabolic, physiological and anatomical changes in the first week of life 60	
including a shift to oxidative metabolism with relative hyperoxia compared to foetal life, increasing 61	
ventricular pressure and accumulation of extracellular matrix [13]. These considerations raised the 62	
possibility that regeneration of the mouse heart could follow cardiac injury in the immediate neonatal 63	
period and indeed complete cardiac regeneration has recently been demonstrated following apex 64	
resection and infarction of the mouse left ventricle (LV) on the first day of postnatal life [14-16]. 65	
Transcriptome analyses in planarians and amphibians have yielded significant insights into the 66	
regulatory mechanisms underlying tissue and organ regeneration in these species [17-19] but 67	
morphological, physiological and genetic differences between these species and mammals limit the 68	
translational potential for application to human disease. They do, however provide the basis of the 69	
molecular investigations in mammals [19]. In mice, the role of individual microRNAs (miRNAs) and 70	
protein-coding messenger RNAs (mRNAs) have been defined by genetic analyses and gene targeting 71	
of specified mRNAs and miRNAs [16, 20, 21]. More recently with recognition of the functions of other 72	
RNA species, certain long non-coding RNAs (lncRNAs) have been implicated in cardiac biology [22], 73	
for example, in protection from cardiac hypertrophy, foetal heart development, and autophagic cell 74	
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death in myocardial infarction [23-26]. Although previous genome-wide studies have examined the 75	
coding transcriptome in neonatal and regenerating heart following apical resection [27], genome-wide 76	
changes in the non-coding transcriptome have not been reported. 77	
Here we have performed an in-depth analysis of the coding and non-coding mouse LV transcriptome 78	
by RNA sequencing at key time points in early postnatal mouse heart development and in the LV during 79	
the period of regeneration following neonatal ligation of the left anterior descending coronary artery 80	
(LAD). The study defines the major sets of coding and non-coding RNAs associated with normal 81	
postnatal cardiac development and with regeneration of the neonatal heart following MI. We perform 82	
functional studies on a key set of exemplar miRNAs in mouse and human cardiomyocytes and identify 83	
conserved roles for these miRNAs in mammalian cardiomyocyte proliferation and mitosis. Our study 84	
provides new insights into the transcriptional regulation of neonatal cardiac development and 85	
regeneration in mammals that will be of value in future comparative and human intervention studies of 86	
cardiac regeneration. 87	
Materials and Methods 88	
Left anterior descending artery (LAD) ligation was performed in P0.5 neonatal C57BL6J mice, as 89	
previously described [15]. Left ventricle (LV) was harvested from three C57BL6J mice from sham-90	
operated and LAD-ligated animals at three, five, seven and 10-days post ligation. Left ventricle (LV) 91	
was also harvested from three C57BL6J mice at P1, P3, P5, P7, P10 (referred to as physiological time 92	
points) in which no surgical procedures had been performed. Coding and non-coding RNA-Seq libraries 93	
were prepared using Illumina TruSeq stranded RNA library preparation and TruSeq small RNA library 94	
preparation kits following manufacturers’ protocols. Mouse genome assembly GCRm38/mm10 and the 95	
Ensembl transcript annotations (version GRCm38.87) were used as the reference sequence in all the 96	
analyses. RNA-Seq reads were quantified using Salmon (v.0.8.2) [28]. Differential expression (DE) 97	
analysis was performed using DESeq2 Bioconductor package. Raw p values were adjusted for multiple 98	
testing with the Benjamini-Hochberg procedure. Weighted gene co-expression cluster analysis 99	
(WGCNA) and a short timer series expression miner (STEM) analysis were performed to identify 100	
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clusters of co-expressed mRNAs. Enrichment of KEGG Pathways for DE mRNAs was calculated using 101	
DAVID (v6.8) across all pairwise comparisons. MiRNA-Seq reads were aligned with Bowtie and 102	
MirDeep2 was used to determine the presence and quantity of miRNAs based on mouse precursor 103	
sequences and mature sequences from mouse and rat with miRBase release 19. MiRNA binding sites 104	
were predicted in-silico across each gene using the union of five separate prediction methods. 105	
Correlation matrices were generated between mRNAs and miRNAs and between mRNAs and 106	
lncRNAs. Potential functional relationships were identified by Spearman correlation, adjusted for 107	
multiple testing correction at FDR < 0.05. P5 mouse cardiomyocytes were treated with mmu-miR-22-108	
5p, mmu-miR-144, mmu-miR-148a-3p, mmu-miR-193a-3p, mmu-miR-193b-3p, mmu-miR-221-3p, 109	
mmu-miR-331-3p, mmu-miR-451a inhibitors and mmu-miR-6240 mimic and iCell® Cardiomyocytes 110	
were treated with human analogues of these miRs. Cells were incubated 10 µM EdU 4 h after seeding 111	
and subsequently fixed with 4% paraformaldehyde and permeabilized in 0.2% (v/v) Triton X-100 112	
before incubation with Click-iT reaction. Hoechst was used for nuclear staining and pH3 to mark mitotic 113	
cells. The analysis was then performed with conventional epifluorescence microscopy. 114	
Results 115	
To define the transcriptional changes occurring during physiological postnatal cardiac development and 116	
after neonatal MI, we generated RNA-Seq expression data of the coding and non-coding transcriptome 117	
from triplicate LV tissue harvested from C57BL/6 mice on postnatal day 0.5, 3.5, 5.5, 7.5 and 10.5, 118	
referred to as P1, P3, P5, P7 and P10, and from LV at 3 to 10 days following LAD ligation (Figure 1). 119	
Transcriptional changes in coding RNA 120	
During the time course of physiological postnatal growth from P1 to P10, we identified 9,450 unique 121	
differentially expressed (DE) mRNAs across all possible pairwise comparisons (Data supplement 1). 122	
We identified an increase in gene expression of 11 cardiomyocyte markers at different time points and 123	
an increase in cardiac fibroblast marker (Ddr2) after P5, reflecting the change in cellular composition 124	
within the LV (Data supplement 2A). WGCNA and STEM analyses of these genes identified clusters 125	
enriched for focal adhesion (p-adj = 1.22E-13), DNA replication (5.47E-16), ribosome (1.64E-50) and 126	
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OXPHOS (p-adj = 0.013) pathways of KEGG analysis (Data supplement 3A, B). These results were 127	
affirmed in pairwise comparisons between time points, with enrichment for DNA replication genes 128	
between P1 and P5, oxidative phosphorylation, focal adhesion genes between P3 and P10, and 129	
ribosomal transcripts throughout a 10-day period (Figure 2A, Data supplement 4). Investigation of 130	
pairwise comparisons between adjacent time points revealed a sharp increase in the number of 131	
differentially expressed genes (DEG) from between P3 to P5 (494) to P5 to P7 (3,545), with the largest 132	
number identified between P7 and P10 (4,375) (Figure 2B Data supplement 5A). Of the 40 most DEG 133	
between P5 and P7, 10 genes (Ube2c, Kif20a, Top2a, Racgap1, Cdca3, Cenpf, Ccna2, Iqgap3, Anln, 134	
Ccnb1 and CenpE) had GO terms associated with mitotic cell cycle process all of which were 135	
downregulated between P5 and P7 (Figure 2C, Data supplement 3). 136	
Following sham operation and LAD ligation, transcriptome analysis showed a large number of DEG 137	
between sham-operated and LAD-ligated mice three days after injury (ShamvLAD (P3) = 2,741). The 138	
number of DEG declined very sharply three days post ligation, with 499 genes found to be DE between 139	
sham and LAD at P5, 112 between sham and LAD at P7, and 61 between sham and LAD-ligated at P10 140	
(Figure 2D, Data supplement 5B). Upregulation of sarcomere expressed Mypn and cardiac fibroblast 141	
marker Ddr2 was observed following LAD ligation at P3 with restoration of physiological expression 142	
profile of cardiomyocyte markers from P7 (Data supplement 2B). 143	
STEM analysis of the post-LAD ligation data showed 15 statistically significant profiles of changing 144	
gene expression, which had generally decreasing gene expression related to immune processes such as 145	
phagosome (p-adj = 5.9E-9) and cytokine-cytokine receptor interaction (p-adj=8.77E-8) (Data 146	
supplement 3C). Four profiles (40, 42, 48 and 49) showed increasing gene expression pattern and were 147	
significantly enriched for OXPHOS which was also observed in the WGCNA analysis (Data 148	
supplement 3C, D). STEM analysis of mRNA expression in the sham-operated mice (P3-P10) showed 149	
pathway enrichment for 13 profiles, mirroring enrichments observed in the physiological samples. 150	
Consistent with the STEM annotation analysis, pairwise comparisons of the sham and LAD data at P3 151	
showed that the major classes of DEG between P3 sham and LAD were within OXPHOS and lysosome 152	
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pathways (Figure 2E, Data supplement 4). Of the top 40 most significant DE mRNAs, we identified 153	
five genes (Fn1, Col1a1, Tnc, Thbs1 and Col1a2) with an increase in expression between sham and 154	
LAD at P3 that are implicated in focal adhesion pathways and three genes (Cd68, Laptm5 and 155	
Atp6v0d2) representing lysosome pathways (Figure 2E, F). Strikingly, 74% of the 3,210 genes that were 156	
DE between sham and LAD were also DE in the pairwise comparisons in the normal physiological data 157	
(Figure 2G). Of the 10,284 DEG, 20 were validated and further characterised by qPCR across all 158	
conditions used in the study using an independent set of triplicate samples (Data supplement 6A). 159	
Changes in non-coding RNA transcriptome 160	
Next, we analysed changes in the expression of non-coding RNAs including lncRNAs and miRNAs in 161	
the normal developing heart. Between all pairwise time point comparisons from P1 to P10, we identified 162	
545 unique DE lncRNAs (Data supplement 1). A fourfold increase in the number of DE lncRNAs was 163	
observed between P3 and P5 (n=24) and between P5 and P7 (n=107) comparisons (Figure 3A). Only 164	
59 of 545 DE lncRNAs have assigned names, for the remainder, there has been limited, functional 165	
characterisation. Four DE lncRNAs between P5vP7, within the top 40 DE, that have names and 166	
functions associated with them include: Nespas, Sorbs2os, H19 and Lockd (Figure 3B, Supplementary 167	
dataset 1). This is the first report showing DE of any of these lncRNAs in the postnatal mammalian 168	
heart. 169	
To explore potential interactions between lncRNAs and mRNAs in the developing heart, we tested for 170	
correlation between lncRNA and mRNA expression across P1 to P10 time points. Of the 545 DE 171	
lncRNAs, 491 correlated significantly (p-adjSpearman < 0.05) with between 1 and 2,604 mRNAs either in 172	
cis or trans. Overall, we found that there were slightly more (median = 26) lncRNAs significantly 173	
correlating in trans compared to in cis (median = 15), implying that their regulatory potential is not 174	
limited by chromosomal location (Figure 3C). 175	
To determine possible functional regulatory roles of DE lncRNAs, we performed a KEGG analysis on 176	
the sets of genes correlating in cis or trans with DE lncRNAs. We identified 86 lncRNAs that correlated 177	
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significantly with gene sets enriched for the ribosome pathway, 113 for oxidative phosphorylation, and 178	
103 with enrichment for the focal adhesion pathway (Data supplement 7). 179	
Between sham-operated and LAD-ligated LV at P3 we identified 51 DE lncRNAs, 55 DE lncRNA at 180	
P5 and eight DE lncRNAs at P7. No DE lncRNAs were identified at P10 (Figure 3E, Data supplement 181	
1), in keeping with the marked reduction in DE mRNAs and miRNAs at later time points. The 51 DE 182	
lncRNAs between sham and LAD comparisons at P3 include the known lncRNAs H19, Dnm3os, Lockd, 183	
Malat1, Meg3, Mhrt, Mirt1, Neat1, Slmapos2, Zfp469 and 41 lncRNAs with unknown function (Figure 184	
3E). A selection of these lncRNAs was significantly correlated with gene sets enriched in ribosome, 185	
OXPHOS, focal adhesion, lysosome and phagosome KEGG pathways (Data supplement 7). Seventy 186	
three of the 109 DE lncRNAs (67%) between sham and LAD were also DE between time points in the 187	
physiological samples (Figure 3F, Data supplement 7). 188	
Analysis of small RNAs identified 413 DE miRNAs across all pairwise comparisons of physiological 189	
time points (Data supplement 8). Expression of 22 of 413 DE miRNAs was tested in separate samples 190	
from different animals, in all time points by qPCR and these were all validated (Data supplement 6B). 191	
The changes were also validated in sorted cells’ subpopulations, showing that the change of expression 192	
occurred both in cardiomyocytes and endothelial cells (data not shown). Of the 413 DE miRNAs, 240 193	
were DE between the P3vP5 time points, 197 were unique (Figure 4A, Data supplement 8). The marked 194	
transition in expression of these miRNAs, between P3 and P5, has not previously been observed. 195	
To identify the potential roles of DE miRNAs during the P1 to P10 time period, we examined the 196	
correlation between the 413 miRNAs that were DE between all the time points and all mRNAs 197	
expressed in these samples, and intersected these data with the in silico predicted binding partners of 198	
the DE miRNAs to give a set of RNAs that correlate with and may be targeted by these miRNAs (Data 199	
supplement 9). We identified 65 unique miRNAs where their significantly correlated gene targets are 200	
enriched for specific KEGG pathways, 34 of which target a total of 67 genes associated with the focal 201	
adhesion pathway (Data supplement 10). Interestingly, orthologues of 49 of these 65 miRNAs were 202	
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also identified in the human genome and these showed conservation of gene targets for a median of 203	
84% of the orthologous genes within the human pathways (Data supplement 10). 204	
We also investigated the temporal relationship between miRNAs and mRNAs. The 240 DE miRNAs, 205	
identified between P3 and P5, are predicted to target 2,731 mRNAs. Of these mRNAs, we observed a 206	
significant overlap with 222 of 494 of DE mRNAs between P3 and P5 (OR=2.09, p=7.51e-15) and 207	
1,091 of the 3,545 DE mRNAs between P5 and P7 (OR=1.18, p=3.79e-4). 208	
Small RNA-seq analysis showed 153 DE miRNAs between sham and LAD three days post ligation, 209	
followed by a marked decline in the number of DE miRNAs between sham and LAD at later time points 210	
(Figure 4D). The top 40 significantly DE miRNAs between sham and LAD at P3 have not been 211	
previously reported as DE following LAD ligation (Figure 4E). The 153 DE miRNAs identified 212	
between sham and LAD at P3 are predicted to target 2,231 mRNAs. Of these 2,231 mRNAs, 1,090 213	
overlap with the 2,741 DE mRNAs identified between sham and LAD at P3 (OR=2.06, p<2.2e-16). 214	
Of the 39 DE miRNAs that correlated with and have predicted targets amongst the DE mRNAs, 14 215	
miRNAs target gene sets of between 9 and 314 genes in pathways for cancer, and 14 miRNAs target 216	
between 13 and 23 mRNAs in focal adhesion (Figure 4E, Data supplement 10). Interestingly, 31 of 39 217	
miRNAs were conserved in humans and targeted a median of 75.7% of the orthologous genes in 218	
corresponding human pathways. Mirroring the mRNA data, 83% of the miRNAs that were DE between 219	
sham and LAD were also DE in the pairwise comparisons between the physiological time points (Figure 220	
4F). 221	
Functional analysis of miR inhibition and overexpression in P5 mouse cardiomyocytes 222	
To test the functional effects of miRNAs on cardiomyocyte proliferation we performed inhibition and 223	
overexpression studies in mouse and human cardiomyocytes, on a set of miRNAs that exhibited 224	
significant changes in physiological and pathological conditions and correlated with changes in mRNA 225	
in focal adhesion pathway We obtained over 80% reduction of the expression of nine miRNAs in 226	
primary mouse cardiomyocytes and a subset of four of their human orthologues in iCell® 227	
cardiomyocytes, and over 50% overexpression of miR-6240 (data not shown). qRT-PCR analysis of 228	
	
	
11	
the expression of cell cycle-regulating cyclins revealed that the levels of Ccna2, CcnD2 and CcnE2 229	
increased significantly (> 2-fold) following treatment with miR-22-5p, miR-451a and miR-195a 230	
inhibitors, and with miR-6240 mimic, in comparison to cells treated with scramble (p < 0.05) (Figure 231	
5A). Treatment with seven other miR inhibitors did not result in any significant changes (p > 0.05) of 232	
tested cyclins expression (Figure 5A). Expression of Ccna1, CcnD1, CcnD3 and CcnE1 did not change 233	
in response to inhibition or overexpression of any of the miRNAs. 234	
To determine whether inhibition or overexpression of these miRs plays a direct role in promoting 235	
cardiomyocyte proliferation we measured the nuclear incorporation of EdU (S-phase marker) and pH3 236	
staining (mitosis marker) in P5 mouse cardiomyocytes. A marked increase in proliferating (EdU 237	
positive) cells (up to 5-fold) was observed for cardiomyocytes treated with miR-22-5p, miR-144-3p, 238	
miR-148a-3p, miR-193a-3p, miR-193b-3p, miR-195a-5p, miR-221-3p, miR-331-3p, miR-451a 239	
inhibitors and miR-6240 mimic (Figure 5B). Likewise, an increase of mitotic (pH3 positive) cells was 240	
seen (up to 3-fold), following treatment with miR-22-5p, miR-195a-5p and miR-451a inhibitors and 241	
miR-6240 mimic (Figure 5C, Data supplement 11A). Scramble-treated mouse cells served as the 242	
negative control for both assays. 243	
Functional analysis of selected miRs in human cardiomyocytes 244	
Given our data showing that several miRNAs regulate aspects of proliferation in P5 mouse 245	
cardiomyocytes, we tested whether the human orthologues of these miRNAs can functionally regulate 246	
cardiomyocyte proliferation in iCell® cardiomyocytes. We transfected iCell® cardiomyocytes with a 247	
subset of human miR inhibitor and mimic orthologues that we had previously tested in mouse 248	
cardiomyocytes. qRT-PCR analysis of cyclins expression revealed elevated levels of Ccna2, CcnD2 249	
and CcnE2 in miR-22-5p, miR-451a and miR-6240 treated cells in comparison with scramble treatment 250	
(p < 0.05) (Figure 5D). As with the mouse miR interventions, levels of Ccna1, CcnD1, CcnD3 and 251	
CcnE1 were unchanged (Figure 5D). iCell® cardiomyocytes treatment with miR-6240 mimic showed 252	
an increase in number of proliferating cells and treatment with miR-144-3p, miR-195a-5p, miR-451a 253	
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and miR-6240 showed up to a 2–fold increase in the number of mitotic cells (Figure 5E, F, Data 254	
supplement 11B). 255	
Discussion 256	
We set out to define the programme of the coding and non-coding transcriptome in the healthy neonatal 257	
heart during the period of loss of regenerative capacity and to relate this to the transcriptional changes 258	
associated with cardiac regeneration following neonatal MI. We found a sharp transition in microRNA 259	
expression in the developing heart between P3 and P5 associated with subsequent changes in expression 260	
of genes on the focal adhesion pathway and cardiomyocyte division arrest. We mapped profound 261	
changes in the transcriptome that returned to normal within 10 days following neonatal MI, indicating 262	
essentially complete healing of the myocardium by this time point, confirming our previous findings 263	
[15]. We showed that two thirds of all RNA species that were DE in the post-MI heart were also DE 264	
during normal postnatal development, suggesting a common regulatory pathway for normal post-natal 265	
cardiac development and post-MI regeneration. Finally, we demonstrated that miR-144-3p, miR-195a-266	
5p and miR-451a inhibition and miR-6240 activation have functionally conserved roles in cell 267	
proliferation and mitosis in mouse and human cardiomyocytes. 268	
We found that the first 10 days of postnatal life were associated with alterations in gene expression of 269	
thousands of genes, particularly those encoding proteins involved in cell cycle progression at early time 270	
points, oxidative phosphorylation at later time points and protein translation throughout. These enriched 271	
pathways are likely reflective of changes in ventricular pressure, transition from hypoxic to the oxygen 272	
rich postnatal environment with increased reliance on oxidative metabolism, and changes in cellular 273	
architecture and the extracellular matrix between P3 and P7 [13, 29]. During the P5 and P7 time 274	
window, one quarter of the most DEG correspond to GO terms associated with M-phase mitosis and 275	
mitotic cell cycle checkpoint, including Cdk1 [30], Ccna2 [31], Cdc13 [32] and Bub1 [33], in keeping 276	
with the withdrawal of cardiomyocytes from DNA replication and cell division at this time point. While 277	
the relative abundance of myocytes, cardiac fibroblasts, endothelial cells and vascular smooth muscle 278	
cells change in the LV during the first ten postnatal days [34] and ontologies and pathways identified 279	
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through our transcriptomic study are in part reflective of this, we were able to identify putative drivers 280	
of cardiomyocyte proliferation and functionally validate them in mouse primary cells and human 281	
cardiomyocyte cell line. 282	
We found major differences in mRNA, miRNA and lncRNA expression between LAD-ligated and 283	
sham-operated mice three days following MI, but these differences had almost completely resolved 284	
within seven days of LAD ligation and increased gene expression of cardiomyocyte markers is restored 285	
to mirror closely the physiological gene expression changes. At the transcriptional level, therefore, the 286	
regenerative process was essentially complete by P10, although certain developmental and cardiac 287	
failure markers, like Nppa [35], remained elevated. The most profoundly DEG three days post LAD 288	
were those involved in immune processes, similarly shown in the contrasting model of heart 289	
regeneration following apex removal together with cell cycle progression and RNA synthesis [27] and 290	
oxidative phosphorylation, in keeping with previous observations of the importance of an active 291	
immune response in physiological regulation of cardiac regeneration in mice [36, 37]. 292	
Similar changes in expression were observed with lncRNAs, where of the 107 DE lncRNAs between 293	
P5 and P7, only seven, including H19 and Neat1, have proposed functions, in cell proliferation [38-40], 294	
and none have been previously associated with postnatal heart development or regeneration. We also 295	
found evidence for trans-regulation of expression by lncRNAs with enrichment amongst correlating 296	
gene sets on OXPHOS, ribosomes and focal adhesion pathways, and show significant enrichment for 297	
imprinting amongst DE lncRNAs. While previously described in other tissues [41], enrichment for 298	
imprinted loci has rarely been observed previously in the postnatal heart or following MI [42]. 299	
We observed a profound shift in microRNA expression in the developing heart between P3 and P5 300	
associated with an altered expression of genes on the focal adhesion pathway between P5 and P7. Since 301	
genes and proteins on the focal adhesion pathway mediate the transduction of external stimuli such as 302	
increasing blood pressure or hypoxia [29, 43, 44] into processes such as DNA replication and cell 303	
division [45], we hypothesise that the set of miRNAs that were DE in the P3 to P5 time window are key 304	
to the regulation of molecular events leading to withdrawal of the cardiomyocyte from cell division in 305	
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the first week of life. To test this hypothesis, we performed in vitro inhibition and over-expression 306	
studies on 10 miRNAs which exhibited significant changes in physiological and pathological 307	
conditions. They include two miRNAs (miR-195a-5p and miR-22-5p) for which previous evidence has 308	
been presented [20, 46]. Our results demonstrate that the inhibition of miR-22-5p and miR-451a and 309	
miR-6240 up-regulation individually elevate the expression of CcnA2, CcnD2 and CcnE2 in P5 mouse 310	
and human cardiomyocytes leading to increased proliferation and cell division. We did not observe 311	
changes in expression of CcnA1 (expressed in germ cells), CcnE1 (lowly expressed in heart), CcnD1 or 312	
CcnD3 (low expression in tested cardiomyocytes) in comparison to scramble-treated cells. Targets of 313	
miR-22 include Map2k1, Map3k9, Rock2 representing the focal adhesion pathway, regulation of cell 314	
proliferation, and Aurkb participating in the regulation of alignment and segregation of chromosomes 315	
during cell division [47]. miR-451a targets Tbx1 and Ybx1 transcription factors regulating proliferation 316	
and differentiation of multipotent heart progenitors [48] and is implicated in translational control of 317	
foetal myocardial gene expression after cardiac transplant [49]. There is limited knowledge on the 318	
functional role of miR-6240, and here we show for the first time, its function in cardiomyocyte 319	
proliferation and heart regeneration in mouse and human cardiomyocytes [50]. Interestingly, miR-22 320	
has been previously found to be highly expressed in cardiac muscle, upregulated during myocyte 321	
differentiation which alone has been found to be sufficient to induce cardiomyocyte hypertrophy. 322	
Our study reports the transcriptional changes in the developing and post-MI postnatal heart and defines 323	
sets of mRNAs, miRNAs and lncRNAs that we propose to be the key regulators, at the level of the 324	
transcriptome, of withdrawal of the postnatal mouse heart from DNA replication and cell division. We 325	
also identify miR-144-3p, miR-195a, miR-451a and miR-6240 as functionally conserved, non-coding 326	
regulators of cardiomyocyte division in neonatal mouse and humans. Whilst we have not studied all the 327	
downstream consequences of our findings, including more detailed impact on protein, cell cycle, and 328	
in vivo validation, our work provides a platform for future studies. 329	
Recent progress in research in developmental cardiology has significantly advanced our understanding 330	
of heart development and regeneration [51]. Insights from zebrafish models of heart regeneration, 331	
following apex removal or cryosurgery, show that they are capable of myocardial regeneration mediated 332	
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mainly through the proliferation of pre-existing gata4+ cardiomyocytes with miR-133 [52] and miR-333	
101 [53], playing regulatory roles in this process, as also shown in our neonatal mouse data set. More 334	
recently, the attempt to pinpoint the regulatory hubs in zebrafish heart regeneration revealed a function 335	
of il6st, adam8, and cd63 [19], also shown to be DE expressed in our post-ligation data sets. Studies of 336	
heart regeneration in neonatal mice reported Myh7 and Igf1r as key drivers of gene interaction networks 337	
and pointing to C1orf61, Aif1, Rock1 as potential inhibitors of cardiomyocyte proliferation and G1/S 338	
phase transition [54], genes that were also DE between physiological time points in our set. In addition, 339	
miRNAs from the miR-15 family [20], miR-503-5p [54], miR-199a [55], miR-99/100 and Let7a/c [21] 340	
were also reported as critical regulators of the regeneration process, which were also found as DE in 341	
our physiological and sham/LAD comparisions in our data set. Interleukin 13, DE in the regenerating 342	
neonatal heart in our data set, has also been identified as a regulator of cardiomyocyte cell cycle entry 343	
mediated by STAT3/periostin and STAT6 [27]. Whilst our data show considerable overlap with 344	
previous observations in mice and zebrafish, we provide a systematic and comprehensive analysis of 345	
coding and non-coding transcriptome changes over multiple time points of the first 10 days of postnatal 346	
life and after neonatal LAD ligation, which has not been available hitherto. 347	
In summary, we present a finely grained time course for mRNA, miRNA and lncRNA in the normal 348	
developing heart from postnatal day 1 (P1) to P10, and in the 3 to 10 days following neonatal MI. We 349	
found profound changes in the coding and non-coding transcriptome after neonatal MI, with evidence 350	
of essentially complete transcriptional healing by P10. We find a sharp transition in miRNA expression 351	
in physiological cardiac samples between P3 and P5, with differentially expressed miRNAs associated 352	
specifically with altered expression of genes on the focal adhesion pathway and cessation of 353	
cardiomyocyte division. Two thirds of each of the mRNAs, lncRNAs and microRNAs that were 354	
differentially expressed in the post-MI heart were also differentially expressed during normal postnatal 355	
development, suggesting a common regulatory pathway for normal cardiac development and post-MI 356	
cardiac regeneration. Of the miRNAs that we implicate in regulation of cardiomyocyte development 357	
and regeneration, 67% had targets that were conserved between mice and humans. We present a subset 358	
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of miRNAs: miR-451a, miR-6240, miR-195a-5p and miR-144-3p that showed functional evidence in 359	
vitro as regulators of cell division in mouse and/or human cardiomyocytes. 360	
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Figure legends 376	
Figure1. Experimental design. 377	
Overview of experimental design showing time points at which LV tissue was harvested (A) during 378	
physiological time points, and following LAD or sham operation. P1-10, postnatal days 1-10; MI 379	
myocardial infarction, (B) sequencing pipeline and (C) functional investigation. 380	
 381	
 382	
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Figure 2. Changes of mRNA expression in physiological LV and following MI. 383	
(A) KEGG pathway analysis between adjacent pairwise comparisons in physiological LV. (B) 384	
Venn diagram showing numbers of DE mRNAs between physiological pairwise comparison (C) Top 385	
40 DE mRNAs between P5 and P7, (D) DE expressed transcripts between LAD and Sham samples-386	
pairwise comparison, (E) KEGG pathway analysis between LAD and Sham samples is pairwise 387	
comparison, (F) Top 40 DE mRNAs between LAD and Sham 3 days post-surgery, (G) Overlap between 388	
DE coding transcripts in physiological and MI LVs. 389	
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Figure 3. Changes of lncRNA expression in physiological LV and following MI. 392	
(A) Venn diagram showing numbers of DE lncRNAs between adjacent pairwise comparisons in 393	
physiological time points. (B) Top 40 most DE transcripts between P5 and P7. (C) The number of 394	
correlating DE mRNAs with DE lncRNAs in the increasing distance from transcription start site (TSS). 395	
(D) Numbers of DE lncRNAs following Sham and LAD operations in pairwise comparisons. (E)	396	
Identities of the most DE lncRNAs between Sham and LAD-operated LVs three days post-surgery. (F) 397	
Overlap between DE lncRNAs between physiological LVs and following surgery. 398	
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Figure 4. Changes of miRNA expression in physiological LV and following MI. 400	
(A) Venn diagram showing numbers of DE miRNAs between adjacent pairwise comparisons in 401	
physiological time points. (B) Heat map showing 40 most DE expressed miRNAs. (C) Focal adhesion 402	
and growth factor pathways diagram showing the genes targeted by DE miRNAs. (D) Numbers of DE 403	
miRNAs following MI. (E) Heat map of the most DE miRNAs three days post MI. (F)	Overlap between 404	
DE miRNAs between physiological LVs and following surgery. 405	
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Figure 5. Functional analysis of miR inhibition and overexpression in P5 mouse and human 408	
cardiomyocytes. 409	
(A)	Changes in mRNA expression of cell cycle regulating cyclins in P5 mouse primary	cardiomyocytes 410	
following treatment with miRNA inhibitors and mimic. A significance indicated by star. EdU and pH3 411	
staining revealing number of proliferating (B) and dividing cells (C) following treatment with miRNAs. 412	
(D) Changes in mRNA expression of cell cycle regulating cyclins in human iPSC derived	413	
cardiomyocytes following treatment with miRNA inhibitors and mimic. A significance indicated by 414	
star. EdU and pH3 staining revealing number of proliferating (E) and dividing cells (F) iPSC derived 415	
cardiomyocytes following treatment with miRNAs. *** p ≤ 0.001, ** p ≤ 0.01, * p≤ 0.05. 416	
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